NCT00250302

Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Hadassah Medical Organization · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Mesenchymal stem cells are found in bone marrow, and have the ability to differentiate into different tissue types. The primary objective of the study is to examine the safety of using such cells to treat patients suffering from distal tibial shaft fractures. The cells will be isolated from the patient's bone marrow, loaded onto a carrier and implanted locally at the fracture site.

Conditions

• Tibial Fracture

Interventions

Type	Name	Description
PROCEDURE	autologous mesenchymal stem cells implantation

Timeline

• Start date: 2009-04-01
• Primary completion: 2011-04-01
• Completion: 2011-04-01
• First posted: 2005-11-08
• Last updated: 2011-04-28

Locations

1 site across 1 country: Israel